Cti Biopharma reported $-12218000 in Operating Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Baxter International BAX:US USD -2799000000 3.15B
Bristol Myers Squibb BMY:US USD 2.47B 117M
Cti Biopharma CTIC:US USD -12218000 6.66M
Cytori Therapeutics CYTX:US USD -5094000 26K
Eli Lilly And LLY:US USD 1.68B 466.4M
Geron GERN:US USD -39948000 11.97M
Mirati Therapeutics MRTX:US USD -186443000 9.24M
Northwest Biotherapeutics NWBO:US USD -16074000 5.14M
Novartis NVS:US USD 2.17B 60M
Novartis NOVN:VX USD 2.17B 60M
Seattle Genetics SGEN:US USD -192805000 59.69M
Teva Pharmaceutical Industries TEVA:US USD 419M 1.37B
YTE INCY:US USD 138.38M 116.06M